Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Caribou Biosciences (CRBU) Accumulated Depreciation & Amortization: 2020-2025

Historic Accumulated Depreciation & Amortization for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $631,000.

  • Caribou Biosciences' Accumulated Depreciation & Amortization fell 46.39% to $631,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 19.06%. This contributed to the annual value of $3.9 million for FY2024, which is 11.40% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Accumulated Depreciation & Amortization is $631,000, which was down 45.93% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Accumulated Depreciation & Amortization peaked at $3.8 million during Q3 2021, and registered a low of $273,000 during Q4 2021.
  • Over the past 3 years, Caribou Biosciences' median Accumulated Depreciation & Amortization value was $856,000 (recorded in 2024), while the average stood at $946,818.
  • Per our database at Business Quant, Caribou Biosciences' Accumulated Depreciation & Amortization crashed by 91.18% in 2021 and then spiked by 250.89% in 2023.
  • Quarterly analysis of 5 years shows Caribou Biosciences' Accumulated Depreciation & Amortization stood at $273,000 in 2021, then surged by 85.35% to $506,000 in 2022, then spiked by 46.25% to $740,000 in 2023, then spiked by 60.00% to $1.2 million in 2024, then crashed by 46.39% to $631,000 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $631,000 for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.